[1] |
Song Chenlu, Qi Xiaojing, Chen Yipeng, Xing Guangqun.
Association of poor living habits and smoking with primary membranous nephropathy
[J]. Clinical Focus, 2025, 40(6): 513-518.
|
[2] |
Kong Li, Zhao Suxian, Zhang Ying, Jin Meng, Wang Shanshan, Ren Weiguang, Zhang Yuguo, Kong Lingbo, Han Fang, Ji Lei.
Expression levels of TIPE2 and FOXP3 in patients with hepatocellular carcinoma and cirrhosis and their clinical significance
[J]. Clinical Focus, 2025, 40(5): 412-416.
|
[3] |
Zhao Xueting, Bai Jiawen, Sun Jun.
Analysis of risk factors for liver fibrosis in metabolic dysfunction-associated fatty liver disease and construction of a nomogram
[J]. Clinical Focus, 2025, 40(5): 417-422.
|
[4] |
Xiao Ke, Wang Qi.
Clinical characteristics and risk factor analysis of type 2 diabetes mellitus complicated with cryptococcal meningitis
[J]. Clinical Focus, 2025, 40(5): 423-427.
|
[5] |
Wang Dongxia, Zhang Dong, Song Shifei, Yang Yimin.
Posterior reversible encephalopathy syndrome following liver transplantation: A case report and literature review
[J]. Clinical Focus, 2025, 40(5): 454-457.
|
[6] |
Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun.
Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis
[J]. Clinical Focus, 2025, 40(4): 293-303.
|
[7] |
Ju Panyu, Yang Fuqi, Zhou Xingjian.
Study on the association between triglyceride-glucose and thyroid nodules in patients with type 2 diabetes mellitus
[J]. Clinical Focus, 2025, 40(4): 329-333.
|
[8] |
Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin.
Value of T2WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients
[J]. Clinical Focus, 2025, 40(3): 251-256.
|
[9] |
Hu Songlin, Di Ya, Liu Canzhang, Yan Jie.
Study on the relationship between platelet/lymphocyte ratio and coronary plaque characteristics in coronary heart disease patients combined with type 2 diabetes mellitus by virtual histology intravascular ultrasound
[J]. Clinical Focus, 2025, 40(2): 117-121.
|
[10] |
Tong Mingxia, Chen Ke, Xiang Xiaocong, Zhou Lifeng.
Analysis of lean metabolic-associated fatty liver disease among young and middle-aged people and its risk factors
[J]. Clinical Focus, 2025, 40(2): 128-132.
|
[11] |
Shi Shuangwei, Rao Xiaojuan, Xie Liran, Fang Yifan, Wang Shanshan.
Correlation between thyroid hormone sensitivity and non-alcoholic fatty liver in type 2 diabetes mellitus patients with normal thyroid function
[J]. Clinical Focus, 2025, 40(2): 133-137.
|
[12] |
Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi.
Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis
[J]. Clinical Focus, 2025, 40(2): 143-146.
|
[13] |
Sun Ya, Yang Shuang.
Value of ultrasound-guided attenuation parameter in the quantitative assessment of hepatic steatosis
[J]. Clinical Focus, 2025, 40(2): 158-161.
|
[14] |
Gou Caixia, Zhang Jie, Baoyixiamu·Ababaikeli , Wang Yiming, Yao Lei, Zheng Rongjiong, Pan Jinliang, Lu Xiaobo.
Analysis of influencing factors of sleep quality and metabolically associated fatty liver disease in the physical examination population
[J]. Clinical Focus, 2025, 40(1): 33-38.
|
[15] |
Ma Jiannan, Tao Jie, Sang Dasen, Wu Shouling, Zhang Qi.
Association of urinary transferrin with new-onset cardiovascular disease in type 2 diabetes mellitus
[J]. Clinical Focus, 2024, 39(8): 700-705.
|